Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.

A device for the treatment of periodontal disease includes a handle that has a configuration familiar to dental professionals, and a detachable tip or cartridge, that is locked into the handle when use. The device provides for automatically delivering a single dose of medicament, such as a powdered preparation of antibiotic, to a periodontal pocket for treatment of infection or disease.

The present invention is directed to delivery device for deploying an insertable into an orifice guided by digit, the delivery device comprising: insertable orientation means adapted to orient the insertable in a deployment orientation and digit orientation means adapted to orient a portion of at least one digit in a navigation orientation, the insertable orientation means and the digit orientation means adjoined across a partition with a partition cross-section, and the deployment orientation and the navigation orientation arranged for digit guided deployment of the insertable into the orifice. Also disclosed is a method of deploying an insertable into an orifice guided by digit, using the delivery device of the present invention. The delivery device and method of the present invention are well suited to deploying tampons into the vaginal cavity.

In an example, a bioresorbable implant for use in a nasal region includes one or more bioresorbable polymers, and a pharmaceutical composition coupled to the one or more bioresorbable polymers. A release rate of the pharmaceutical composition is related to a degradation rate of the one or more bioresorbable polymers.

The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.

A single-use suppository insertion device includes a barrel, a plunger configured to be movably coupled to the barrel, and a disabling feature of the barrel or the plunger. The disabling feature may be configured to be activated during operational motion of the plunger relative to the barrel, such as during insertion of or withdrawal away from a suppository. The device can include a structural element of the barrel or the plunger configured to engage with the disabling feature of the barrel or the plunger during insertion of or withdrawal away from the suppository to activate the disabling feature. The disabling feature may be implemented in a number of ways to ensure single-use operation of the single-use suppository insertion device.

A medicant dispenser enabling the effective administration of tableted pharmaceutical products within a body cavity has a plunger, a barrel, and a deformable tip. The deformable tip provides a suitable leading element to allow the barrel to enter the body cavity, wherein the plunger may be pushed to eject the tableted pharmaceutical products into the body cavity through the deformable tip. More specifically, the deformable tip will comprise a plurality of cuspids fixed to a support ring, wherein the support ring is fitted to a terminal end of the barrel. The plurality of cuspids will collapse concentrically to form a tapered leading element of the medicant applicator while retaining the capacity to separate to allow passage of the tableted pharmaceutical products and a head of the plunger therethrough.

Implantable drug delivery devices include a housing having a closed drug reservoir lumen bounded by a first wall structure and a hydrophilic second wall structure, and a drug contained in the drug reservoir lumen, wherein the first wall structure is impermeable to the drug and the second wall structure is permeable to the drug. Methods of providing controlled release of drug to a patient include deploying a drug delivery device in the patient releasing a drug from the drug reservoir lumen via diffusion through the second wall structure.

The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.

A medicinal applicator that is defined by a base, a medicinal cream receiving port in the base, and a shaft extending along a shaft axis from the base and terminating at an applicator tip is useful in smearing medicinal cream in a person's colon. There is at least one exit aperture located along a portion of the shaft through which the cream can exit. The medicinal applicator has an unobstructed pathway is in communication with the receiving port and the exit aperture in addition to a stop plate that extends radially from the base delineating the base from the shaft. The shaft's outer shape is defined by an oblong cross section that is uniform along the entire length of the shaft.